Project-29
Development of a multi-biomarker concept combining dCu, TK1 and CRP inflammatory activity for veterinary monitoring.
Veterinary biomarkers
Animal Health
An analytical approach based on copper isotopes to support veterinary oncology monitoring.
Innovation
Biomarkers and copper isotopic variation
Delta-Biomarkers is behind an innovation in the biomarker field, showing a relationship between cancer monitoring in living organisms and copper isotopic variation (dCu).
Our large database, built from more than 6,000 human and animal samples, gives us strong insight into the natural and pathological variations of this biomarker.
Application field
Companion animals, zoo felids and clinical monitoring
Our technology is also used in the field of neurodegenerative diseases and with physicians specialised in anti-ageing medicine.
Our core focus is the use of this cancer-related marker in veterinary medicine, particularly for companion animals, mainly dogs, but also zoo felids for which we now have a significant database.
Clinical studies
Oncology follow-up and recurrence monitoring
Our first clinical follow-up studies on more than one hundred dogs showed strong results and higher specificity than commonly used data such as CRP or other inflammation markers.
After a two-year follow-up on 77 dogs, our biomarker enabled the diagnosis of more than 85% of cancers, including lymphomas. This level can reach 99% when TK1 measurement is added. We also obtained more than 85% recurrence detection over the follow-up period using copper alone.
Animal health applications
Fur analysis
Mineral analysis and interpretation in the context of nutrition, toxicology and veterinary follow-up.
Natural variation
Use of a multi-thousand-sample database to contextualise analytical results.
Technologies
Analytical approach
Our markers are supported by ICP-MS and MC-ICP-MS platforms and specialised analytical workflows.
dCu
TK1
CRP
ICP-MS
MC-ICP-MS
Veterinary monitoring
Contact
Discuss an analytical question
Tell us about your matrix, objectives and technical constraints.